These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31935617)

  • 21. EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
    Fenizia F; De Luca A; Pasquale R; Sacco A; Forgione L; Lambiase M; Iannaccone A; Chicchinelli N; Franco R; Rossi A; Morabito A; Rocco G; Piccirillo MC; Normanno N
    Future Oncol; 2015; 11(11):1611-23. PubMed ID: 26043215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
    Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
    Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.
    Mayo-de-Las-Casas C; Garzón Ibáñez M; Jordana-Ariza N; García-Peláez B; Balada-Bel A; Villatoro S; Malapelle U; Karachaliou N; Troncone G; Rosell R; Molina-Vila MA
    Expert Rev Mol Diagn; 2018 Jan; 18(1):35-45. PubMed ID: 29172773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide-Affinity Precipitation of Extracellular Vesicles and Cell-Free DNA Improves Sequencing Performance for the Detection of Pathogenic Mutations in Lung Cancer Patient Plasma.
    Taylor C; Chacko S; Davey M; Lacroix J; MacPherson A; Finn N; Wajnberg G; Ghosh A; Crapoulet N; Lewis SM; Ouellette RJ
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-biopsy and liquid biopsy for patients with non-small cell lung cancer after EGFR-tyrosine kinase inhibitor failure.
    Zhou J; Zhao C; Zhao J; Wang Q; Chu X; Li J; Zhou F; Ren S; Li X; Su C; Zhou C
    Thorac Cancer; 2019 Apr; 10(4):957-965. PubMed ID: 30887673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. There is still a role for cytology in the 'liquid biopsy' era. A lesson from a TKI-treated patient showing adenocarcinoma to squamous cell carcinoma transition during disease progression.
    Clery E; Pisapia P; Feliciano S; Vigliar E; Marano A; De Luca C; Malapelle U; Troncone G; Bellevicine C
    J Clin Pathol; 2017 Sep; 70(9):798-802. PubMed ID: 28363898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
    Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
    Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Liquid biopsy : A blood sample for early recognition and therapy control in lung cancer patients].
    Hekmat K; Bruns C
    Chirurg; 2017 Jul; 88(7):621. PubMed ID: 28616676
    [No Abstract]   [Full Text] [Related]  

  • 29. Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
    Kim E; Feldman R; Wistuba II
    Clin Lung Cancer; 2018 Mar; 19(2):105-114. PubMed ID: 28935493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.
    Guibert N; Tsukada H; Hwang DH; Chambers E; Cibas ES; Bale T; Supplee J; Ulrich B; Sholl LM; Paweletz CP; Oxnard GR
    Lung Cancer; 2018 Aug; 122():72-75. PubMed ID: 30032849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
    Ai B; Liu H; Huang Y; Peng P
    Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.
    Bennett CW; Berchem G; Kim YJ; El-Khoury V
    Oncotarget; 2016 Oct; 7(43):71013-71035. PubMed ID: 27589834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA methylation biomarkers discovered
    Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
    Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
    Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Feasibility of cell-free circulating tumor DNA testing for lung cancer.
    Santarpia M; Karachaliou N; González-Cao M; Altavilla G; Giovannetti E; Rosell R
    Biomark Med; 2016; 10(4):417-30. PubMed ID: 26974841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
    Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
    Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid Biopsy in Tumor Genetic Diagnosis.
    Jung A; Kirchner T
    Dtsch Arztebl Int; 2018 Mar; 115(10):169-174. PubMed ID: 29587961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer.
    Cui S; Zhang W; Xiong L; Pan F; Niu Y; Chu T; Wang H; Zhao Y; Jiang L
    Oncotarget; 2017 Jan; 8(2):2771-2780. PubMed ID: 27926526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.